- Home
- CLBK vs DNTH Comparison
CLBK vs DNTH Comparison
Compare CLBK & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBK
- DNTH
- Stock Information
- Founded
- CLBK 1927
- DNTH 2015
- Country
- CLBK United States
- DNTH United States
- Employees
- CLBK N/A
- DNTH N/A
- Industry
- CLBK Savings Institutions
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- CLBK Finance
- DNTH Health Care
- Exchange
- CLBK Nasdaq
- DNTH Nasdaq
- Market Cap
- CLBK 1.6B
- DNTH 1.5B
- IPO Year
- CLBK N/A
- DNTH N/A
- Fundamental
- Price
- CLBK $15.42
- DNTH $38.88
- Analyst Decision
- CLBK Hold
- DNTH Strong Buy
- Analyst Count
- CLBK 1
- DNTH 10
- Target Price
- CLBK $16.00
- DNTH $66.38
- AVG Volume (30 Days)
- CLBK 115.8K
- DNTH 989.4K
- Earning Date
- CLBK 10-23-2025
- DNTH 11-06-2025
- Dividend Yield
- CLBK N/A
- DNTH N/A
- EPS Growth
- CLBK N/A
- DNTH N/A
- EPS
- CLBK 0.06
- DNTH N/A
- Revenue
- CLBK $187,256,000.00
- DNTH $4,854,000.00
- Revenue This Year
- CLBK $31.86
- DNTH N/A
- Revenue Next Year
- CLBK $13.37
- DNTH N/A
- P/E Ratio
- CLBK $257.13
- DNTH N/A
- Revenue Growth
- CLBK N/A
- DNTH 17.87
- 52 Week Low
- CLBK $12.64
- DNTH $13.37
- 52 Week High
- CLBK $19.28
- DNTH $39.70
- Technical
- Relative Strength Index (RSI)
- CLBK 60.20
- DNTH 84.91
- Support Level
- CLBK $14.72
- DNTH $36.00
- Resistance Level
- CLBK $15.47
- DNTH $24.81
- Average True Range (ATR)
- CLBK 0.34
- DNTH 2.76
- MACD
- CLBK 0.02
- DNTH 1.05
- Stochastic Oscillator
- CLBK 64.52
- DNTH 95.37
About CLBK Columbia Financial Inc.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.